Intrinsic Value of S&P & Nasdaq Contact Us

TILT Holdings Inc. TLLTF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
10/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

TILT Holdings Inc. (TLLTF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 10/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $116M, -16.4%/yr average growth. Net income is $95M (loss), growing at -49.4%/yr. Net profit margin is -82.1% (negative). Gross margin is 17.3% (-11.4 pp trend).

Balance sheet: total debt is $130M with negative equity of -$37M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.47 (tight liquidity). Debt-to-assets is 85.7%. Total assets: $151M.

Analyst outlook: 0 / 1 analysts rate TLLTF as buy (0%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 0/100 (Fail), Moat 15/100 (Fail), Future 20/100 (Fail), Income 10/100 (Fail).

TLLTF SharesGrow Score Overview

15/100
SharesGrow Score
Weak fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 15/100
Gross margin is + market cap
FUTURE 20/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.0001-0.012
Volume1.04M
Avg Volume (30D)65.72K
Market Cap$34.75K
Beta (1Y)-0.13
Share Statistics
EPS (TTM)-0.26
Shares Outstanding$388.71M
IPO Date2021-01-08
Employees292
CEOTim Conder
Financial Highlights & Ratios
Revenue (TTM)$115.61M
Gross Profit$20.05M
EBITDA$-46.49M
Net Income$-94.88M
Operating Income$-69.43M
Total Cash$3M
Total Debt$129.63M
Net Debt$126.62M
Total Assets$151.32M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Rating ConsensusHold
Analysts Covering1
Buy 0% Hold 100% Sell 0%
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINCA88688R1047

Price Chart

TLLTF
TILT Holdings Inc.  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.01
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message